The estimated 453,000 infections and 29,300 deaths caused by Clostridium difficile in the United States in 2011 underline the importance of appropriat... More »
The Clostridium difficile bacterium resulted in nearly 500,000 infections and 29,000 deaths in the United States in 2011, Dr. Fernanda C. Lessa and he... More »
PHILADELPHIA – Clostridium difficile infections among nursing home residents resulted in some 31,000 hospitalizations and 9,000 deaths nationally in 2012, population-based surveillance data...
PHILADELPHIA – Receiving a flu shot cut the odds of influenza hospitalizations by 56% among older adults during the 2010-1011 flu season, surveillance data show.
Vaccine effectiveness was...
PHILADELPHIA – Every recurrence of Clostridium difficile was associated with a hospital admission in 1 in 4 cases and a complication in 1 in 15 cases, according to a retrospective Canadian...
Dalbavancin is the first drug with a Qualified Infectious Disease Product designation to be approved by the Food and Drug Administration.
On May 23, the agency approved dalbavancin (<link...
SILVER SPRING, MD. – A Food and Drug Administration advisory committee voted unanimously to support the approval of the antibacterial drug dalbavancin for the treatment of acute bacterial skin and...
Protocol-based resuscitation did not reduce sepsis deaths or morbidity, compared with usual care, in the Protocolized Care for Early Septic Shock study conducted at 31 U.S. academic hospitals.
Among...
So far, the 2013-2014 influenza season has been hardest on young and middle-age adults, with 61% of flu hospitalizations occurring in the 18- to 64-year-old age group, the Centers for Disease Control...
A warning about cases of pancytopenia linked to the use of the oral hepatitis C antiviral drug boceprevir has been added to the drug’s label, the Food and Drug Administration has announced.
There...